NCT06351748 - Real-world Study of CHina Ozempic cLinicAl pRactice in Patients With Type 2 Diabetes (SCHOLAR) | Biotech Hunter

Enrollment

34,238

Participants

Timeline

Start Date

January 2, 2024

Primary Completion Date

March 29, 2024

Study Completion Date

March 29, 2024

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

Semaglutide

Participants received semaglutide OW according to local label and to routine clinical practice at the discretion of the treating physician.

Trial Locations (1)

Tianjin Medical University Chu Hsien-I Memorial Hospital, Tianjin